Madri­gal's $600M of­fer­ing; PureTech to re­turn $100M to share­hold­ers

Plus, news about Out­look Ther­a­peu­tics, Geron, Fate Ther­a­peu­tics, En­liv­en Ther­a­peu­tics, See­los and Por­tal Biotech­nolo­gies:

Madri­gal Phar­ma­ceu­ti­cals’s $600M of­fer­ing: The com­pa­ny is rais­ing mon­ey to boost …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.